We recently identified three distinct phenotypes of language comprehension in 31,000 autistic individuals (Vyshedskiy, Venkatesh, & Khokhlovich, 2024): 1) individuals with the Command Phenotype were limited to comprehension of simple commands; 2) individuals with the Modifier Phenotype demonstrated additional comprehension of color, size, and number modifiers; and 3) individuals with the Syntactic Phenotype added comprehension of spatial prepositions, verb tenses, flexible syntax, possessive pronouns, complex explanations, and fairytales. We hypothesized that typically developing children progress through the same three language comprehension phenotypes and aimed to investigate the typical age at which each phenotype emerged. To evaluate comprehension in young children, we developed a new assessment, the 15-item Language Phenotype Assessment (LPA), which utilizes toy-animal manipulatives to avoid reliance on picture interpretation and includes short instructions to reduce auditory memory load. The LPA was administered to 116 typically-developing children aged 1.5 to 7 years. Results revealed a developmental pattern in line with the three previously described phenotypes: 50% of typically developing children attained the Command Phenotype by 1.5-years, the Modifier Phenotype by 3.0-years, and the Syntactic Phenotype by 3.7-years-of-age. Future research should focus on establishing normative data for the LPA to enable earlier identification of language comprehension challenges, facilitating timely initiation of language interventions.
Competing Interest StatementThe authors have declared no competing interest.
Funding StatementThis research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study adhered to all local regulations. Using the Department of Health and Human Services regulations found at 45 CFR 46.101(b)(4), the Biomedical Research Alliance of New York LLC Institutional Review Board (IRB) determined that this research project is exempt from IRB oversight. In Brazil, the study received IRB approval from Centro Universitario Dinamica das Cataratas (Foz do Iguacu, Brazil).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data AvailabilityDe-identified raw data from this manuscript are available from the corresponding author upon reasonable request.
留言 (0)